Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2008-07-01
2008-07-01
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C424S141100, C424S145100, C435S007100, C435S810000, C435S975000, C530S387900, C530S388100, C530S388150
Reexamination Certificate
active
11483312
ABSTRACT:
Nucleic acids encoding mammalian, e.g., primate, IL-1ζ, purified IL-1ζ polypeptides and fragments thereof. Binding proteins, e.g., antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 6117654 (2000-09-01), Pan
patent: 7033783 (2006-04-01), Sims et al.
patent: 0 541 920 (1993-05-01), None
patent: 0 855 404 (1998-07-01), None
patent: WO 99/06426 (1999-02-01), None
patent: WO 99/07850 (1999-02-01), None
patent: WO 99/36541 (1999-07-01), None
Arnon and Van Regenmortel, (1992)The FASEB Journal6:3265-3274 “Structural basis of antigenic specificity and design of new vaccines”.
Auron, et al., GenPept, Accession No. 124303, Jul. 15, 1998. Definition: Interleukin-1 Beta Precursor (IL-1 Beta) (Catabolin).
Bancroft, et al., Immunol. Reviews, 124:5-24, 1991. “Natural Immunity: A T-Cell-Independent Pathway of Macrophage Activation, Defined in the scid Mouse”.
Bazan, et al., Nature, 379:591, Feb. 15, 1996. “A newly defined interleukin-1?”.
Belvin, et al., Annu. Rev. Cell Dev. Biol., 12:393-416, 1996. “A conserved signaling pathway; The Drosophila TollDorsal Pathway”.
Benjamin, et al. (1998)Development125:1591-1598 “A plasticity window for blodd vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF”.
Carrier, GenBank, Accession No. X64532, Jun. 25, 1997. Definition: “H.sapiens gene for interleukin-1 receptor antagonist”.
Carter, et al., GenPept, Accession No. 124312, Jul. 15, 1998. Definition: Interleukin-1 receptor antagonist protein precursor (IL-1RA) (ICIL-1RA) (IRAP).
Cominelli, et al., J. Biol. Chem., 296(9):6962-6971, Mar. 4, 1994. “Rabbit Interleukin-1 Receptor Antagonist”.
Cominelli, et al., GenBank, Accession No. S68977, Sep. 22, 1994. Definition: “sIL-1ra=interleukin-1 receptor antagonist secreted form [rabbits, colon tissue, mRNA, 574 nt.]”.
Dinarello, Blood, 77(8):1638-1652, Apr. 15, 1991. “Interleukin-1 and Interleukin-Antagonism”.
Dinarello, The FASEB Journal, 8:1314-1325, Dec. 1994. “The interleukin-1 family: 10 years of discovery”.
Dinarello, Blood, 87(6):2095-2147, Mar. 15, 1996. “Biologic Basis for interleukin-1 in Disease”.
Gao, W., et al. (2003)J. Immunol.170:107-113 “Innate Immunity Mediated by the Cytokine IL-1 Homologue 4 (IL-1H4/IL-1F7) Induces IL-12-Dependent Adaptive and Profound Antitumor Immunity”.
Gilmore, et al., GenBank, Accession No. Z70047, Mar. 11, 1996. Definition: “C.familiaris mRNA for interleukin-1 beta”.
Goto, et al., GenBank, Accession No. D21832, Apr. 21, 1994. Definition: “Rabbit mRNA for interleukin-1 receptor antagonist, complete cds.”
Gronenborn and Clore, Protein Engineering, 4(3):263-269, 1991. “Modeling the three-dimensional structure of the monocyte chemo-attractant and activating protein MCAF/MCP-1 on the basis of the solution structure of interleukin-8”.
Hamada and Mulligan, et al., GenBank, Accession No. M57526, Jan. 30, 1992. Definition: “Rabbit interleukin-1 receptor antagonist (IL1RA) mRNA, complete cds.”
Hanks, et al., Methods in Enzymology, 2000:38-62, 1991. “[2] Protein Kinase Catalytic Domain Sequence Database: Identification of Conserved Features of Primary Structure and Classification of Family Members”.
Hannon, et al., GenBank, Accession No. I09591, Nov. 14, 1994. Definition: “Sequence 1 from Patent WO 8911540”.
Hannon, et al., GenBank, Accession No. I09592, Nov. 14, 1994. Definition: “Sequence 3 from Patent WO 8911540”.
Hultmark, Nature, 367:116-117, Jan. 13, 1994. “Ancient Relationships”.
Hunter, et al., J. Immunology, 155:4347-4345, 1995. “IL-1β Is Required for IL-12 to induce Production of IFN-γ by NK Cells. A Role for IL-1β in the T Cell-Independent Mechanism of Resistance Against Intracellular Pathogens.”
Jenkins, et al., GenBank, Accession No. U65590, Dec. 22, 1997. Definition: “Homo sapiensIL-1 receptor antagonist IL-1Ra (IL-1RN) gene, alternatively spliced forms, complete cds.”
Kumar, S., et al, GenBank, Locus Q9NZH6, 218 aa, linear, PRI Jan. 24, 2006 Definition: Interleukin-1 family member 7 precursor (IL-1F7) (Interleukin-1 zeta) (IL-1 zeta) (FIL1 zeta) (Interleukin-1 homolog 4) (IL-1H4) (Interleukin-1-related protein) (IL-1RP1) (IL-1X protein).
Kumar, et al. (2000)J. Biol. Chem.275:10308-10314 “Identification and initial characterization of four novel members of the interleukin-1 family”.
Lemaitre, et al., Cell, 86:973-983, Sep. 20, 1996. “The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosphila Adults”.
Leong, GenBank, Accession No. X12497, Mar. 13, 1995. Definition: “Bovine mRNA for interleukin-1 alpha”.
Lodi, et al., Science, 263:1762-1767, Mar. 25, 1994. “High-Resolution Structure of the β Chemokine hMIP-1β by Multidimensional NMR”.
Maliszewski, GenBank, Accession No. X52731, Mar. 31, 1995. Definition: “Pig mRNA for interleukin 1-alpha”.
March, et al., GenPept, Accession No. 124297, Oct. 1, 1996. Definition: “Interleukin-1 alpha precursor (IL-1 alpha (hematopoietin-1))”.
Marra, et al., GenBank, Accession No. AA030324, Jan. 21, 1997. Definition: “mi08c10.r1 Soares mouse placenta 4NbMP13.5 14.5 Mus musculus cDNA clone 459858 5′, mRNA sequence”.
Marra, et al., GenBank, Accession No. W08205, Sep. 5, 1996. Definition: “mb49b11.r1 Soares mouse p3NMF19.5 Mus musculus cDNA clone 332733 5′ similar to PIR:A49031 A49031 interleukin 1 receptor antagonist—mouse ; mRNA sequence”.
Masaaki, et al., GenBank, Accession No. E01109, Nov. 26, 1996. Definition: “cDNA sequence of human IL-1”.
Masaaki, et al., GenBank, Accession No. E01442, Nov. 26, 1996. Definition: “cDNA encoding human IL-1”.
McMahan, et al., The EMBO Journal, 10(10):2821-2832, Oct. 1991. “A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types”.
Morisato and Anderson, Annu. Rev. Genetics, 29:371-399, 1995. “Signaling pathways that establish the dorsal-ventral pattern of the Drosophilia embryo”.
Nishida, et al., GenBank, Accession No. D00403, Jan. 19, 1992. Definition: “Rat interleukin-1 alpha mRNA, complete cds.”
Okamura, et al., Nature, 378:88-91, Nov. 2, 1995. “Cloning of a new cytokine that induces IFN-g production by T cells”.
Oppenheim, et al., Ann. Rev. Immunol. 9:617-648, 1991, “Properties of the novel proinflammatory supergene ‘intercrine’ cytokine family”.
Parker, et al., Nature, 363:736-738, Jun. 24, 1993. “Phosphorylation and inactivation of the mitotic inhibitor Wee1 by the nim1/cdr1 kinase”.
Rothe, et al., The Journal of Clinical Investigation, 99(3):469-474, Feb. 1997. “Active Stage of Autoimmune Diabetes Is Associated with the Expression of a Novel Cytokine, IGIF, Which Is Located Near Idd2”.
Sayle and Milner-White, TIBS, 20:374-376, Sep. 1995. “Rasmol: biomolecular graphics for all”.
Seow, GenBank, Accession No. X56972, May 26, 1992. Definition: “Ovine IL-1 beta mRNA for interleukin-1 beta”.
Skolnick, et al. (2000)Nature Biotechnology18:283-287 “Structural genomics and its importance for gene function analysis”.
Smith, et al. J. Biol. Chem. 275(2):1169-1175, Jan. 14, 2000. “Four new members expand the interleukin-1 superfamily”.
Storkus, W.J., et al. “Interleukin-12” in: Thomson,The Cytokine Handbook, (3rded., Academic Press, 1998) pp. 391-425. ISBN 0-12-689662-3.
Stratagene Catalog, 1988, p. 39.
Strausberg (NCI-CGAP), GenBank, Accessi
Bellomy Gregory R.
Ching Edwin P.
Mertz Prema
Schering Corporation
LandOfFree
IL-1-like cytokine antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-1-like cytokine antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-1-like cytokine antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3920578